Contact Us

Saadia Pharmaceuticals’ Team Publishes Spravato® (Janssen Pharmaceuticals) 4-Year Experience Paper in Current Psychiatry

Share an article:

Other News

  • In The News

Saadia Pharmaceuticals Team Delivers NEI Podcast Discussing Vraylar®(Abbvie).

Learn More
  • Posters & Publications

Saadia Pharmaceuticals’ Team Publishes Spravato® (Janssen) Review Article in Biomarkers in Neuropsychiatry

Learn More
  • Posters & Publications

Saadia Pharmaceuticals’ Team Gives Presentation to 900K Prescribers on Vumedi

Learn More
  • Posters & Publications

Saadia Pharmaceuticals’ Team Publishes Rebutal on Vraylar® (AbbVie Pharmaceuticals) study on use for Bipolar I Disorder Maintenance

Learn More
  • Posters & Publications

Saadia Pharmaceuticals’ Team Presents Treatment-Resistant Major Depressive Disorder Study Poster at Hackensack Meridian School of Medicine 2024

Learn More
  • Posters & Publications

Saadia Pharmaceuticals’ Team Publishes Lybalvi® (Alkermes Pharmaceuticals) Case Series in Journal of Clinical Psychiatry Primary Care Companion for CNS Disorders

Learn More

© 2024 Saadia Pharmaceuticals, Inc. All Rights Reserved.

© 2024 Saadia Pharmaceuticals, Inc.